COLD EMULSIFICATION TECHNOLOGY IN THE PRODUCTION OF MEDICINAL OINTMENTS AND ITS ADVANTAGES
DOI:
https://doi.org/10.55640/Keywords:
cold emulsification, semi-solid dosage forms, medicinal ointment, emulsification, thermolabile substances, emulsifier, dispersity, stability, technological process.Abstract
This article examines the cold emulsification technology applied in the manufacturing of medicinal ointments (semi-solid dosage forms). Cold emulsification is a technique in which aqueous and oily phases are combined without heating or with minimal thermal exposure. This approach ensures the stability of thermolabile active ingredients, prevents degradation of auxiliary excipients, and reduces energy consumption during production. The study analyzes the technological stages, criteria for selecting emulsifiers, phase compatibility, and the physicochemical characteristics of the final product. The results demonstrate that ointments manufactured by cold emulsification possess enhanced dispersity, uniform consistency, and increased formulation stability.Downloads
References
1.Yunusxo‘jayev A.Y., Ibragimov A.X. Pharmaceutical Technology (Semi-solid Dosage Forms). Tashkent: Medical Publishing House, 2020.
2.Ostonova G.R., Karimova M.J. Fundamentals of Drug Formulation Technology. Tashkent: Science and Technology Press.
3.Xo‘jaqulova M.S. Introduction to Pharmaceutical Dosage Form Technology.
4.Saidov M.S., Jo‘rayev K.A. Technology of Active Substances and Excipients.
5.Sultanov N.A. Technology of Emulsions and Suspensions.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India